Annual CFI
-$127.01 M
+$23.19 M+15.44%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual cash flow from investing activities is -$127.01 million, with the most recent change of +$23.19 million (+15.44%) on December 31, 2023.
- During the last 3 years, PLRX annual CFI has risen by +$83.85 million (+39.77%).
- PLRX annual CFI is now -272.34% below its all-time high of $73.70 million, reached on December 31, 2021.
Performance
PLRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$30.96 M
+$20.26 M+189.29%
September 30, 2024
Summary
- As of February 7, 2025, PLRX quarterly cash flow from investing activities is $30.96 million, with the most recent change of +$20.26 million (+189.29%) on September 30, 2024.
- Over the past year, PLRX quarterly CFI has increased by +$20.26 million (+189.29%).
- PLRX quarterly CFI is now -48.01% below its all-time high of $59.55 million, reached on March 31, 2024.
Performance
PLRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$133.13 M
-$7.29 M-5.19%
September 30, 2024
Summary
- As of February 7, 2025, PLRX TTM cash flow from investing activities is $133.13 million, with the most recent change of -$7.29 million (-5.19%) on September 30, 2024.
- Over the past year, PLRX TTM CFI has dropped by -$7.29 million (-5.19%).
- PLRX TTM CFI is now -5.19% below its all-time high of $140.42 million, reached on June 30, 2024.
Performance
PLRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PLRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.4% | +189.3% | -5.2% |
| 3 y3 years | +39.8% | +189.3% | -5.2% |
| 5 y5 years | -5367.6% | +437.2% | +842.5% |
PLRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -272.3% | +15.4% | -48.0% | +117.4% | -5.2% | +137.5% |
| 5 y | 5-year | -272.3% | +39.8% | -48.0% | +117.4% | -5.2% | +137.5% |
| alltime | all time | -272.3% | +39.8% | -48.0% | +117.4% | -5.2% | +137.5% |
Pliant Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $30.96 M(+189.3%) | $133.13 M(-5.2%) |
| Jun 2024 | - | $10.70 M(-82.0%) | $140.42 M(+31.6%) |
| Mar 2024 | - | $59.55 M(+86.5%) | $106.74 M(-184.0%) |
| Dec 2023 | -$127.01 M(-15.4%) | $31.92 M(-16.6%) | -$127.01 M(-8.6%) |
| Sep 2023 | - | $38.25 M(-266.5%) | -$138.91 M(-60.9%) |
| Jun 2023 | - | -$22.98 M(-86.8%) | -$355.42 M(+9.0%) |
| Mar 2023 | - | -$174.21 M(-970.1%) | -$325.94 M(+117.0%) |
| Dec 2022 | -$150.20 M(-303.8%) | $20.02 M(-111.2%) | -$150.20 M(+4.0%) |
| Sep 2022 | - | -$178.25 M(-2844.4%) | -$144.44 M(-319.2%) |
| Jun 2022 | - | $6.50 M(+324.2%) | $65.91 M(+4.6%) |
| Mar 2022 | - | $1.53 M(-94.1%) | $63.00 M(-14.5%) |
| Dec 2021 | $73.70 M | $25.78 M(-19.7%) | $73.70 M(+23.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $32.10 M(+795.6%) | $59.82 M(-177.3%) |
| Jun 2021 | - | $3.58 M(-70.7%) | -$77.36 M(-58.7%) |
| Mar 2021 | - | $12.23 M(+2.7%) | -$187.26 M(-11.2%) |
| Dec 2020 | -$210.87 M(+1076.0%) | $11.91 M(-111.3%) | -$210.87 M(-9.1%) |
| Sep 2020 | - | -$105.08 M(-1.2%) | -$231.95 M(+105.0%) |
| Jun 2020 | - | -$106.32 M(+834.8%) | -$113.13 M(+5895.0%) |
| Mar 2020 | - | -$11.37 M(+23.9%) | -$1.89 M(-89.5%) |
| Dec 2019 | -$17.93 M(+671.9%) | -$9.18 M(-166.8%) | -$17.93 M(+104.9%) |
| Sep 2019 | - | $13.75 M(+179.4%) | -$8.75 M(-61.1%) |
| Jun 2019 | - | $4.92 M(-117.9%) | -$22.50 M(-17.9%) |
| Mar 2019 | - | -$27.42 M | -$27.42 M |
| Dec 2018 | -$2.32 M | - | - |
FAQ
- What is Pliant Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Pliant Therapeutics?
- What is Pliant Therapeutics annual CFI year-on-year change?
- What is Pliant Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly CFI year-on-year change?
- What is Pliant Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Pliant Therapeutics?
- What is Pliant Therapeutics TTM CFI year-on-year change?
What is Pliant Therapeutics annual cash flow from investing activities?
The current annual CFI of PLRX is -$127.01 M
What is the all time high annual CFI for Pliant Therapeutics?
Pliant Therapeutics all-time high annual cash flow from investing activities is $73.70 M
What is Pliant Therapeutics annual CFI year-on-year change?
Over the past year, PLRX annual cash flow from investing activities has changed by +$23.19 M (+15.44%)
What is Pliant Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PLRX is $30.96 M
What is the all time high quarterly CFI for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly cash flow from investing activities is $59.55 M
What is Pliant Therapeutics quarterly CFI year-on-year change?
Over the past year, PLRX quarterly cash flow from investing activities has changed by +$20.26 M (+189.29%)
What is Pliant Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PLRX is $133.13 M
What is the all time high TTM CFI for Pliant Therapeutics?
Pliant Therapeutics all-time high TTM cash flow from investing activities is $140.42 M
What is Pliant Therapeutics TTM CFI year-on-year change?
Over the past year, PLRX TTM cash flow from investing activities has changed by -$7.29 M (-5.19%)